HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Keiichi Yamanaka Selected Research
Keiichi Yamanaka Research Topics
Disease
14
Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 04/2003
14
Dermatitis
06/2022 - 08/2008
10
Atopic Dermatitis (Atopic Eczema)
06/2021 - 12/2006
9
Inflammation (Inflammations)
05/2022 - 08/2010
9
Neoplasms (Cancer)
01/2022 - 03/2005
7
Infections
11/2021 - 01/2012
5
Skin Diseases (Skin Disease)
05/2022 - 01/2014
5
Amyloidosis
05/2022 - 01/2014
4
Pyoderma Gangrenosum
05/2022 - 08/2015
4
Autoimmune Diseases (Autoimmune Disease)
01/2019 - 09/2004
3
Rheumatoid Arthritis
10/2022 - 01/2019
3
Atrophy
06/2022 - 01/2012
3
Ulcer
05/2022 - 12/2020
3
Melanoma (Melanoma, Malignant)
01/2022 - 08/2010
3
Disseminated Intravascular Coagulation
09/2021 - 11/2015
3
Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 01/2014
3
Hypersensitivity (Allergy)
01/2017 - 08/2008
2
Fibrosis (Cirrhosis)
06/2022 - 10/2021
2
Necrosis
01/2022 - 03/2003
2
Vitiligo
01/2022 - 01/2012
2
Thrombosis (Thrombus)
11/2021 - 09/2018
2
Urticaria (Hives)
09/2021 - 01/2021
2
Cytokine Release Syndrome
09/2021 - 08/2021
2
Spotted Fever Group Rickettsiosis (Rickettsialpox)
08/2021 - 11/2018
2
Erythema
05/2021 - 10/2020
2
Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
05/2021 - 09/2020
2
Granuloma
04/2021 - 01/2011
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 10/2020
2
Heart Failure
09/2020 - 01/2018
2
Emaciation
09/2020 - 01/2014
2
Connective Tissue Diseases (Connective Tissue Disease)
01/2019 - 09/2018
2
Systemic Scleroderma (Systemic Sclerosis)
01/2019 - 09/2018
2
Pathologic Constriction (Stenosis)
10/2018 - 03/2003
2
Cardiomegaly (Heart Hypertrophy)
01/2018 - 01/2014
2
Paramyxoviridae Infections (Parainfluenza)
01/2017 - 01/2013
2
Pruritus (Itching)
03/2014 - 08/2008
1
Respiratory Insufficiency (Respiratory Failure)
10/2022
1
Interstitial Lung Diseases (Interstitial Lung Disease)
10/2022
1
Eosinophilic Fasciitis
03/2022
1
Fasciitis (Fascitis)
03/2022
1
Breast Neoplasms (Breast Cancer)
01/2022
1
Triple Negative Breast Neoplasms
01/2022
1
Amyloid Plaque
01/2022
1
Myocarditis (Carditis)
01/2022
1
Sarcoidosis (Schaumann Disease)
01/2022
1
Body Weight (Weight, Body)
12/2021
1
Hypoalbuminemia
12/2021
Drug/Important Bio-Agent (IBA)
18
Cytokines
IBA
06/2022 - 02/2009
6
Amyloid (Amyloid Fibrils)
IBA
06/2022 - 01/2014
6
Interleukin-17 (Interleukin 17)
IBA
05/2022 - 07/2017
5
Antigens
IBA
09/2021 - 01/2013
4
Prednisolone (Predate)
FDA Link
Generic
03/2022 - 03/2003
3
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2022
3
fibrin fragment D (D-dimer)
IBA
11/2021 - 09/2018
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2021 - 08/2014
3
Interleukins
IBA
06/2021 - 08/2014
3
Immunoglobulin G (IgG)
IBA
06/2021 - 06/2016
3
Interleukin-18 (Interleukin 18)
IBA
08/2010 - 12/2006
2
Imiquimod (Aldara)
FDA Link
Generic
10/2022 - 05/2020
2
Pharmaceutical Preparations
IBA
10/2022 - 09/2004
2
Infliximab (Remicade)
FDA Link
10/2022 - 01/2021
2
Therapeutic Uses
IBA
05/2022 - 02/2009
2
Janus Kinase Inhibitors
IBA
05/2022 - 12/2021
2
Prostaglandins A
IBA
05/2022 - 12/2020
2
Adalimumab (Humira)
FDA Link
05/2022 - 12/2020
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2018
2
Antibodies
IBA
12/2021 - 06/2016
2
Immunoglobulin E (IgE)
IBA
09/2021 - 11/2018
2
Interleukin-6 (Interleukin 6)
IBA
08/2021 - 09/2019
2
Steroids
IBA
08/2021 - 01/2012
2
Messenger RNA (mRNA)
IBA
05/2020 - 07/2009
2
Vaccines
IBA
04/2020 - 01/2013
2
tocilizumab (atlizumab)
FDA Link
09/2019 - 01/2019
2
Cyclosporine (Ciclosporin)
FDA Link
Generic
06/2019 - 01/2012
2
Immunoglobulins (Immunoglobulin)
IBA
06/2019 - 06/2016
2
beta-cyclodextrin tetradecasulfate (CTDS)
IBA
01/2019 - 09/2018
2
Monoclonal Antibodies
IBA
01/2019 - 08/2014
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2019 - 01/2012
2
Enzymes
IBA
06/2016 - 08/2010
2
Interleukin-12 (IL 12)
IBA
08/2014 - 01/2012
2
Proteins (Proteins, Gene)
FDA Link
04/2013 - 07/2009
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2012 - 12/2003
2
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2012 - 09/2004
1
Biosimilar Pharmaceuticals
IBA
10/2022
1
CT-P13
IBA
10/2022
1
Pilocarpine (Ocusert)
FDA Link
Generic
06/2022
1
Janus Kinases
IBA
05/2022
1
Interleukin-33
IBA
03/2022
1
atezolizumab
IBA
01/2022
1
Prealbumin (Transthyretin)
IBA
01/2022
1
Troponin
IBA
01/2022
1
130-nm albumin-bound paclitaxel
IBA
01/2022
1
Serum Albumin
IBA
12/2021
1
fluorescein isothiocyanate dextran
IBA
12/2021
1
Peptides (Polypeptides)
IBA
10/2021
1
Carcinoembryonic Antigen
IBA
09/2021
Therapy/Procedure
15
Therapeutics
01/2022 - 03/2005
3
Biological Therapy
10/2022 - 08/2014
3
Drug Therapy (Chemotherapy)
01/2022 - 01/2020
2
Skin Transplantation (Skin Grafting)
09/2021 - 04/2013